Bafna Pharmaceuticals Ltd - Stock Price

As on22 Oct 2021
  • NSE : BAFNAPH
  • BSE : 532989
  • ISIN CODE : INE878I01022
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Bafna Pharmaceuticals Ltd is not traded on BSE/NSE
NSE
130.80
-1.36 %-1.8
BSE
130.60
+0.35 %+0.45

Balance Sheet

Parameter MAR 20  MAR 19  YoY %Change
EQUITY AND LIABILITIESNANANA
Share Capital23.66236.56-90.00
    Equity - Authorised400.00400.000.00
    Equity - Issued23.66236.56-90.00
    Equity Paid Up23.66236.56-90.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value10.0010.000.00
Share Warrants & Outstandings553.560.000.00
Total Reserves-66.07-45.98-43.68
    Securities Premium413.11413.110.00
    Capital Reserves284.1156.91399.26
    Profit & Loss Account Balance-781.82-534.53-46.26
    General Reserves18.5218.520.00
    Other Reserves0.000.000.00
Reserve excluding Revaluation Reserve-66.07-45.98-43.68
Revaluation reserve0.000.000.00
Shareholder's Funds511.15190.58168.20
Minority Interest0.81-2.06139.16
Long-Term Borrowings0.000.000.00
Secured Loans0.00208.58-100.00
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks0.00188.19-100.00
    Term Loans - Institutions0.000.000.00
    Other Secured0.0020.39-100.00
Unsecured Loans30.1821.3141.63
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)0.000.000.00
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.0.000.000.00
    Loans - Others30.1821.3141.63
    Other Unsecured Loan0.000.000.00
Deferred Tax Assets / Liabilities0.0061.79-100.00
    Deferred Tax Assets0.000.000.00
    Deferred Tax Liability0.0061.79-100.00
Other Long Term Liabilities0.006.32-100.00
Long Term Trade Payables0.000.000.00
Long Term Provisions0.000.000.00
Total Non-Current Liabilities30.18297.99-89.87
Current LiabilitiesNANANA
Trade Payables125.41395.59-68.30
    Sundry Creditors125.41395.59-68.30
    Acceptances0.000.000.00
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities45.5880.23-43.18
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers25.1012.54100.22
    Interest Accrued But Not Due0.000.000.00
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities20.4867.69-69.74
Short Term Borrowings0.00232.40-100.00
    Secured ST Loans repayable on Demands0.00232.40-100.00
    Working Capital Loans- Sec0.00232.40-100.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans0.00-232.40100.00
Short Term Provisions0.000.000.00
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax0.000.000.00
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions0.000.000.00
Total Current Liabilities171.00708.21-75.86
Total Liabilities713.131194.72-40.31
ASSETSNANANA
Gross Block741.26729.101.67
Less: Accumulated Depreciation391.21358.559.11
Less: Impairment of Assets0.000.000.00
Net Block350.05370.55-5.53
Lease Adjustment A/c0.000.000.00
Capital Work in Progress2.120.000.00
Non Current Investments0.000.000.00
Long Term Investment0.000.000.00
    Quoted0.000.000.00
    Unquoted0.000.000.00
Long Term Loans & Advances0.00329.53-100.00
Other Non Current Assets0.009.95-100.00
Total Non-Current Assets352.17710.03-50.40
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Quoted0.000.000.00
    Unquoted0.000.000.00
Inventories114.1292.8222.94
    Raw Materials44.3129.2051.74
    Work-in Progress29.1812.85127.11
    Finished Goods26.8510.81148.46
    Packing Materials12.028.9234.69
    Stores  and Spare1.7631.05-94.34
    Other Inventory0.000.000.00
Sundry Debtors60.35248.34-75.70
    Debtors more than Six months7.52184.96-95.93
    Debtors Others52.8363.38-16.65
Cash and Bank84.8127.13212.57
    Cash in hand0.040.0343.33
    Balances at Bank84.7627.10212.76
    Other cash and bank balances0.000.000.00
Other Current Assets74.1962.3818.93
    Interest accrued on Investments0.000.000.00
    Interest accrued on Debentures0.000.000.00
    Deposits with Government3.112.8010.96
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses1.280.8061.01
    Other current_assets69.8058.7918.74
Short Term Loans and Advances27.5054.02-49.10
    Advances recoverable in cash or in kind20.300.000.00
    Advance income tax and TDS6.475.5416.80
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances0.7348.48-98.50
Total Current Assets360.96484.69-25.53
Net Current Assets (Including Current Investments)189.96-223.52184.99
Miscellaneous Expenses not written off0.000.000.00
Total Assets713.131194.72-40.31
Contingent Liabilities0.250.250.00
Total Debt30.18462.28-93.47
Book Value-17.938.06-322.54
Adjusted Book Value-17.938.06-322.54

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 130.6. Its current market capitalisation stands at Rs 308.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 712.18 Cr and Total Income of Rs.719.67 Cr. The company's management includes Akilapriya Chandrashekar Raju, Shanmugam Hemalatha, Jitendra Kumar Pal, R Chitra, Atul Sachdeva, B Kamlesh Kumar, P K Sundaresan.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

Latest News

close